It's been over a year since COVID-19 has impacted our lives
No human bioavailability data exist for oral, sublingual, or transdermal routes, so claims that one route works better in people are unsupported
TB-500 provides critical enhancement of cellular migration and epithelial coverage that drives wound closure, with research demonstrating that topical or intraperitoneal TB-500 administration increases reepithelialization by 42% over controls at 4 days post-wounding and 61% at 7 days, with treated wounds showing enhanced contraction (at least 11% more than controls by day 7) and superior architectural organization
Vafadar A, Shabaninejad Z, Movahedpour A, Fallahi F, Taghavipour M, Ghasemi Y, Akbari M, Shafiee A, Hajighadimi S, Moradizarmehri S, Razi E (2020) Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells
Zhang J, Pavlova NN, Thompson CB
Raphael AP, Crichton ML, Falconer RJ, Meliga S, Chen X, Fernando GJP, Huang H, Kendall MAF
